##fileformat=VCFv4.1
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##INFO=<ID=CADD_SCALED,Number=.,Type=Float,Description="Since the raw scores do have relative meaning, one can take a specific group of variants, define the rank for each variant within that group, and then use that value as a \"normalized\" and now externally comparable unit of analysis. In our case, we scored and ranked all ~8.6 billion SNVs of the GRCh37/hg19 reference and then \"PHRED-scaled\" those values by expressing the rank in order of magnitude terms rather than the precise rank itself. For example, reference genome single nucleotide variants at the 10th-% of CADD scores are assigned to CADD-10, top 1% to CADD-20, top 0.1% to CADD-30, etc. The results of this transformation are the \"scaled\" CADD scores.(source: http://cadd.gs.washington.edu/info)">
##INFO=<ID=ANN,Number=.,Type=String,Description="Functional annotations: 'Allele | Annotation | Annotation_Impact | Gene_Name | Gene_ID | Feature_Type | Feature_ID | Transcript_BioType | Rank | HGVS.c | HGVS.p | cDNA.pos / cDNA.length | CDS.pos / CDS.length | AA.pos / AA.length | Distance | ERRORS / WARNINGS / INFO' ">
##INFO=<ID=EXAC_AF,Number=.,Type=String,Description="The ExAC allele frequency">
##INFO=<ID=GoNL_AF,Number=.,Type=String,Description="The allele frequency for variants seen in the population used for the GoNL project">
##INFO=<ID=Thousand_Genomes_AF,Number=.,Type=String,Description="The allele frequency for variants seen in the population used for the thousand genomes project">
##INFO=<ID=RLV,Number=.,Type=String,Description="Allele | AlleleFreq | Gene | FDR | Transcript | Phenotype | PhenotypeInheritance | PhenotypeOnset | PhenotypeDetails | PhenotypeGroup | SampleStatus | SamplePhenotype | SampleGenotype | SampleGroup | VariantSignificance | VariantSignificanceSource | VariantSignificanceJustification | VariantCompoundHet | VariantGroup">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	1	.	A	G	11026.7	.	CADD_SCALED=34.0;ANN=G||HIGH|ADCY5||AR||||||||||;GoNL_AF=0.02;Thousand_Genomes_AF=3.99361E-4;RLV=G|0.0|ADCY5|||Dyskinesia  familial  with facial myokymia|DOMINANT|Adult|||p03:AFFECTED/p02:AFFECTED||p03:1s1/p02:0s1||Predicted pathogenic|GAVIN|Variant CADD score of 34.0 is greater than 30.82 for this gene.||;
1	2	.	G	A	6733.05	.	CADD_SCALED=34.0;ANN=A||HIGH|ABCG5||AD||||||||||;GoNL_AF=0.06;Thousand_Genomes_AF=3.99361E-4;RLV=A|0.0|ABCG5|||Sitosterolemia|RECESSIVE|Pediatric|||p03:AFFECTED/p02:CARRIER||p03:1s1/p02:0s1||Predicted pathogenic|GAVIN|Variant CADD score of 34.0 is greater than 28.35 in a gene for which CADD scores are informative.||;
1	3	.	G	A	6733.05	.	CADD_SCALED=34.0;ANN=A||HIGH|AIFM1||XL||||||||||;GoNL_AF=0.03;Thousand_Genomes_AF=3.99361E-4;RLV=A|0.0|AIFM1|||Deafness  X-linked 5|XL_LINKED|Pediatric|||p03:AFFECTED/p02:CARRIER||p03:1/p02:0s1||Predicted pathogenic|GAVIN|Variant CADD score of 34.0 is greater than 21.53 in a gene for which CADD scores are informative.||;
1	4	.	G	A	6733.05	.	CADD_SCALED=34.0;ANN=A||HIGH|ALB||AD/AR||||||||||;GoNL_AF=0.07;Thousand_Genomes_AF=3.99361E-4;RLV=A|0.0|ALB|||Dysalbuminemic hyperthyroxinemia  Analbuminemia|DOMINANT_OR_RECESSIVE|Pediatric|Depending on the disorder  manifestations may primarily affect the endocrine system (as in Dysalbuminemic hyperthyroxinemia) or may result in findings such as edema and hypercholesterolemia  as well as pharmacogenomic implications (as in Analbuminemia)||p03:AFFECTED/p02:AFFECTED||p03:1s1/p02:0s1||Predicted pathogenic|GAVIN|Variant CADD score of 34.0 is greater than 26.49 for this gene.||;
1	5	.	G	T,C	20111.87	.	CADD_SCALED=34.0,.;ANN=T||HIGH|USP9Y||YL||||||||||,C||HIGH|USP9Y||YL||||||||||;GoNL_AF=0.01,.;Thousand_Genomes_AF=3.99361E-4,.;RLV=T|0.0|USP9Y|||Spermatogenic failure  Y-linked  2|OTHER|N A|||p03:HOMOZYGOUS||p03:1||Predicted pathogenic|GAVIN|Variant MAF of 0.0 is rare enough to be potentially pathogenic and its CADD score of 34.0 is greater than a global threshold of 15.||;
